Skip to main content
SSKN logo
SSKN
(NASDAQ)
STRATA Skin Sciences, Inc.
$0.20-- (--)
Loading... - Market loading

STRATA Skin Sciences (SSKN) Balance Sheet

Assets, liabilities, and shareholders' equity with annual and quarterly data.

STRATA Skin Sciences Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for STRATA Skin Sciences, Inc. (SSKN) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period EndingDec 2025Dec 2024Dec 2023Mar 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Current Assets
Cash and Cash Equivalents7.917.266.785.435.4312.5910.608.1316.494.07
Cash & Short-Term Investments7.917.266.785.435.4312.5910.608.1316.494.07
Accounts Receivable4.125.254.444.474.473.432.944.393.393.14
Inventory2.812.252.675.553.103.493.443.032.793.01
Other Current Assets0.751.841.652.050.690.467.848.010.541.07
Total Current Assets15.6016.6015.5417.5015.0519.9724.8323.5623.2110.75
Non-Current Assets
Property, Plant & Equipment (Net)9.8811.3312.408.4710.937.526.526.685.307.70
Goodwill1.432.666.528.808.808.808.808.808.808.80
Intangible Assets3.385.357.3217.3917.3910.086.357.969.7711.33
Other Non-Current Assets0.230.230.230.100.100.220.280.350.430.05
Total Non-Current Assets14.9219.5626.4734.7737.2226.6221.9523.7924.3027.88
Total Assets30.5236.1642.0252.2752.2746.5946.7847.3447.5138.63
Current Liabilities
Accounts Payable2.762.433.343.433.432.822.761.881.762.28
Short-Term Debt15.350.330.350.360.000.329.127.590.252.74
Accrued Liabilities0.490.440.310.000.570.630.000.000.000.00
Deferred Revenue2.252.242.122.782.783.292.262.832.100.29
Other Current Liabilities0.003.252.042.880.312.681.591.941.784.55
Total Current Liabilities26.7414.6312.1713.4313.4312.8018.8417.438.627.67
Non-Current Liabilities
Long-Term Debt0.6916.1115.288.097.487.321.761.087.157.85
Deferred Tax Liabilities0.000.000.190.310.310.270.25-0.120.110.41
Other Non-Current Liabilities0.180.451.698.318.620.400.030.180.390.51
Total Non-Current Liabilities0.8716.5617.1517.0217.028.382.051.267.648.71
Total Liabilities27.6131.1929.3330.4430.4421.1820.8918.6916.2616.39
Stockholders' Equity
Common Stock0.010.000.000.040.040.030.030.030.030.00
Retained Earnings-254.41-248.14-238.06-227.23-227.23-221.68-218.97-214.56-210.77-229.41
Accumulated Other Comprehensive Income0.000.000.000.000.000.000.000.00-13.53-10.73
Additional Paid-in Capital257.31253.11250.74249.02249.02247.06244.83243.18241.99223.83
Shares Outstanding5.894.173.510.003.473.440.000.000.000.00
Total Stockholders' Equity2.914.9712.6921.8321.8325.4125.8928.6531.2522.25
Total Liabilities & Equity30.5236.1642.0252.2752.2746.5946.7847.3447.5138.63

Frequently Asked Questions About STRATA Skin Sciences Balance Sheet

What is a balance sheet?

A balance sheet shows a company's financial position at a specific point in time. It lists total assets (what the company owns), total liabilities (what it owes), and stockholders' equity (the difference). The fundamental equation: Assets = Liabilities + Equity.

What is stockholders' equity?

Stockholders' equity represents the net value belonging to shareholders — total assets minus total liabilities. It includes retained earnings, common stock, and additional paid-in capital. Growing equity over time typically indicates a healthy, profitable business.

What is working capital?

Working capital is current assets minus current liabilities. It measures a company's ability to pay short-term obligations with short-term assets. Positive working capital indicates the company can cover its near-term debts; negative may signal liquidity risk.

What is SSKN's debt level?

Review STRATA Skin Sciences's total long-term debt and short-term borrowings in the balance sheet table above. Compare debt to equity and total assets to assess leverage and financial risk.

What is book value per share?

Book value per share is total stockholders' equity divided by shares outstanding. It represents the accounting value per share if the company were liquidated. Comparing market price to book value gives the price-to-book (P/B) ratio — a key valuation metric.

These financial metrics are calculated using balance sheet data. Learn how each metric works and screen stocks by them.